Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Laboratory Corp American Holdings (NY:LH)

265.36 +2.85 (+1.09%)
Streaming Delayed Price Updated: 12:12 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Laboratory Corp American Holdings

< Previous 1 2 3 4 Next >
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapies 
From Predictive Oncology Inc.
Via GlobeNewswire
Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience
From Praia Health
Via Business Wire
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
From NOWDiagnostics, Inc.
Via Business Wire
Is This Telehealth Stock a Buy After the Recent Pullback?
Hims & Hers Health leverages telehealth's accessibility to disrupt traditional healthcare and deliver personalized wellness solutions. 
Via MarketBeat
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp
From Xcell Biosciences Inc.
Via Business Wire
LifeMD Shares Come Back to Life on GLP-1 Business Growth
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 
Via MarketBeat
Laboratory Corp. of America Holdings (NYSE: LH) Records 52-Week High Tuesday Morning
Via Investor Brand Network
LifeMD expands telehealth GLP-1weight-loss service with Medifast
LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing 
Via MarketBeat
2 aerospace stocks are ready to take flight on the next leg up
The aerospace sector has been red hot in 2023; here are two surging aerospace stocks with the potential to reach even higher altitudes 
Via MarketBeat
Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of Directors
From Singular Genomics Systems, Inc.
Via GlobeNewswire
Enzo Biochem Completes Sale of Clinical Laboratory to Labcorp
From Enzo Biochem, Inc.
Via GlobeNewswire
Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster
From Fortrea Holdings Inc
Via GlobeNewswire
Exact Sciences Serves Investors Exactly What They Wished For
Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The 
Via MarketBeat
Ovia HealthTM Expands Digital Platform Capabilities to Include Menopause Tracking
From Labcorp
Via Business Wire
Labcorp Announces 2022 Fourth Quarter and Full-Year Results
From Labcorp
Via Business Wire
Labcorp Unveils New Name for Future Independent Clinical Development Business - Fortrea
From Labcorp
Via Business Wire
Labcorp to Announce Fourth Quarter and Full Year 2022 Financial Results on February 16, 2023
From Labcorp
Via Business Wire
Labcorp Declares Quarterly Dividend
From Labcorp
Via Business Wire
Thomas Pike to Join Labcorp as President and Chief Executive Officer of Its Drug Development Clinical Development Business Unit
From Labcorp
Via Business Wire
Labcorp to Speak at the 41st Annual J.P. Morgan Healthcare Conference
From Labcorp
Via Business Wire
Labcorp Opens New Los Angeles Based Laboratory
From Labcorp
Via Business Wire
Labcorp to Speak at the Credit Suisse 31st Annual Healthcare Conference
From Labcorp
Via Business Wire
Here’s Why Quest Diagnostics Stock Should Be in Your Portfolio
Medical diagnostic lab company Quest Diagnostic (NYSE: DGX) stock has been trading within a boxed range from $126 to $146 for the majority of 2022. 
Via MarketBeat
Labcorp Announces 2022 Third Quarter Results
From Labcorp
Via Business Wire
Labcorp Appoints Google Cloud Executive Kirsten Kliphouse to Its Board of Directors
From Labcorp
Via Business Wire
Labcorp Declares Quarterly Dividend
From Labcorp
Via Business Wire
Labcorp Establishes Comprehensive Laboratory Relationship With Ascension
From Labcorp
Via Business Wire
Labcorp to Announce Third Quarter Financial Results on October 27, 2022
From Labcorp
Via Business Wire
Labcorp to Speak at the Baird 2022 Global Healthcare Conference
From Labcorp
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.